Related references
Note: Only part of the references are listed.A Population-Based Clinical Trial Comparing Endocervical High-Risk HPV Testing Using Hybrid Capture 2 and Cervista From the SHENCCAST II Study
Jerome L. Belinson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
Francesca M. Carozzi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Prospects for new human papillomavirus vaccines
Margaret Stanley
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
Mark H. Einstein et al.
GYNECOLOGIC ONCOLOGY (2010)
Comparison of Time Trends in Uterus Cancer and Cervix Uteri Cancer Mortality (1990-2006) in the World, from the WHO Mortality Database
Ming-Ji Zhang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Using acetowhite opacity index for detecting cervical intraepithelial neoplasia
Wenjing Li et al.
JOURNAL OF BIOMEDICAL OPTICS (2009)
Cervical cancer screening, abnormal cytology management, and counseling practices in the United States
Kathleen Irwin et al.
OBSTETRICS AND GYNECOLOGY (2006)
Cost-effectiveness of cervical-cancer screening in five developing countries
SJ Goldie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
D Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
The 2001 Bethesda System - Terminology for reporting results of cervical cytology
D Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
